These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11429125)

  • 41. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication.
    Boyer JD; Robinson TM; Maciag PC; Peng X; Johnson RS; Pavlakis G; Lewis MG; Shen A; Siliciano R; Brown CR; Weiner DB; Paterson Y
    Virology; 2005 Mar; 333(1):88-101. PubMed ID: 15708595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques.
    Hidajat R; Xiao P; Zhou Q; Venzon D; Summers LE; Kalyanaraman VS; Montefiori DC; Robert-Guroff M
    J Virol; 2009 Jan; 83(2):791-801. PubMed ID: 18971271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An SAMT-247 Microbicide Provides Potent Protection against Intravaginal Simian Immunodeficiency Virus Infection of Rhesus Macaques, whereas an Added Vaccine Component Elicits Mixed Outcomes.
    Helmold Hait S; Hogge CJ; Rahman MA; Ko EJ; Hunegnaw R; Mushtaq Z; Enyindah-Asonye G; Hoang T; Miller Jenkins LM; Appella E; Appella DH; Robert-Guroff M
    J Immunol; 2020 Jun; 204(12):3315-3328. PubMed ID: 32393514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.
    Van Rompay KK; Abel K; Earl P; Kozlowski PA; Easlick J; Moore J; Buonocore-Buzzelli L; Schmidt KA; Wilson RL; Simon I; Moss B; Rose N; Rose J; Marthas ML
    Vaccine; 2010 Feb; 28(6):1481-92. PubMed ID: 19995539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine.
    Robinson JE; Cole KS; Elliott DH; Lam H; Amedee AM; Means R; Desrosiers RC; Clements J; Montelaro RC; Murphey-Corb M
    AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1253-62. PubMed ID: 9764909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challenge.
    Xiao P; Patterson LJ; Kuate S; Brocca-Cofano E; Thomas MA; Venzon D; Zhao J; DiPasquale J; Fenizia C; Lee EM; Kalisz I; Kalyanaraman VS; Pal R; Montefiori D; Keele BF; Robert-Guroff M
    J Virol; 2012 Apr; 86(8):4644-57. PubMed ID: 22345466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
    Cole KS; Alvarez M; Elliott DH; Lam H; Martin E; Chau T; Micken K; Rowles JL; Clements JE; Murphey-Corb M; Montelaro RC; Robinson JE
    Virology; 2001 Nov; 290(1):59-73. PubMed ID: 11883006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T
    Helmold Hait S; Hogge CJ; Rahman MA; Hunegnaw R; Mushtaq Z; Hoang T; Robert-Guroff M
    Front Immunol; 2020; 11():608003. PubMed ID: 33584682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody-secreting cells specific for simian immunodeficiency virus antigens in lymphoid and mucosal tissues of immunized macaques.
    Bergmeier LA; Mitchell EA; Hall G; Cranage MP; Cook N; Dennis M; Lehner T
    AIDS; 1998 Jul; 12(10):1139-47. PubMed ID: 9677162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge.
    Vogel TU; Beer BE; Zur Megede J; Ihlenfeldt HG; Jung G; Holzammer S; Watkins DI; Altman JD; Kurth R; Norley S
    J Gen Virol; 2002 Jan; 83(Pt 1):81-91. PubMed ID: 11752704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination.
    Kent SJ; Hu SL; Corey L; Morton WR; Greenberg PD
    J Virol; 1996 Aug; 70(8):4941-7. PubMed ID: 8763998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Whole inactivated SIV virion vaccines with functional envelope glycoproteins: safety, immunogenicity, and activity against intrarectal challenge.
    Lifson JD; Piatak M; Rossio JL; Bess J; Chertova E; Schneider D; Kiser R; Coalter V; Poore B; Imming R; Desrosiers RC; Henderson LE; Arthur LO
    J Med Primatol; 2002 Aug; 31(4-5):205-16. PubMed ID: 12390543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaques.
    Hel Z; Nacsa J; Tsai WP; Thornton A; Giuliani L; Tartaglia J; Franchini G
    Virology; 2002 Dec; 304(1):125-34. PubMed ID: 12490410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine.
    Hel Z; Johnson JM; Tryniszewska E; Tsai WP; Harrod R; Fullen J; Tartaglia J; Franchini G
    Vaccine; 2002 Aug; 20(25-26):3171-86. PubMed ID: 12163269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition.
    Gordon SN; Liyanage NP; Doster MN; Vaccari M; Vargas-Inchaustegui DA; Pegu P; Schifanella L; Shen X; Tomaras GD; Rao M; Billings EA; Schwartz J; Prado I; Bobb K; Zhang W; Montefiori DC; Foulds KE; Ferrari G; Robert-Guroff M; Roederer M; Phan TB; Forthal DN; Stablein DM; Phogat S; Venzon DJ; Fouts T; Franchini G
    J Immunol; 2016 Oct; 197(7):2726-37. PubMed ID: 27591322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens.
    Penaloza MacMaster P; Shields JL; Alayo QA; Cabral C; Jimenez J; Mondesir J; Chandrashekar A; Cabral JM; Lim M; Iampietro MJ; Provine NM; Bricault CA; Seaman M; Orlinger K; Aspoeck A; Fuhrmann G; Lilja AE; Monath T; Mangeat B; Pinschewer DD; Barouch DH
    Vaccine; 2017 Jan; 35(1):1-9. PubMed ID: 27899229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques.
    Sixsmith JD; Panas MW; Lee S; Gillard GO; White K; Lifton MA; Balachandran H; Mach L; Miller JP; Lavine C; DeMarco CT; Tomaras GD; Gee C; Porcelli SA; Larsen MH; Frothingham R; Schmitz JE; Jacobs WR; Haynes BF; Letvin NL; Korioth-Schmitz B
    Clin Vaccine Immunol; 2014 Oct; 21(10):1385-95. PubMed ID: 25080550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors.
    Falkensammer B; Rubner B; Hiltgartner A; Wilflingseder D; Stahl Hennig C; Kuate S; Uberla K; Norley S; Strasak A; Racz P; Stoiber H
    Retrovirology; 2009 Jun; 6():60. PubMed ID: 19545395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques.
    Johnson PR; Schnepp BC; Connell MJ; Rohne D; Robinson S; Krivulka GR; Lord CI; Zinn R; Montefiori DC; Letvin NL; Clark KR
    J Virol; 2005 Jan; 79(2):955-65. PubMed ID: 15613324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope.
    Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC
    J Immunol; 2002 Apr; 168(8):4001-11. PubMed ID: 11937557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.